News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

SRI International Awarded Defense Advanced Research Projects Agency Subcontract to Accelerate Vaccine Manufacturing Process


7/17/2007 11:30:35 AM

MENLO PARK, Calif.--(BUSINESS WIRE)--SRI International, an independent nonprofit research and development organization, announced today that it will collaborate with Neugenesis Corporation, a biotechnology company developing complex protein biotherapeutics, to develop technologies for the rapid manufacturing of vaccines and drugs. The SRI-awarded subcontract is part of a major contract awarded to Neugenesis by the Defense Advanced Research Projects Agency (DARPA).

Read at BioSpace.com


comments powered by Disqus
   
Vaccine

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES